World's Best Scientists 2026 revealed!
Susumu Kusunoki

Susumu Kusunoki

D-Index & Metrics

Immunology

D-Index
65
Citations
15908
World Ranking
2836
National Ranking
117

Susumu Kusunoki publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Susumu Kusunoki sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 436 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Susumu Kusunoki D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Susumu Kusunoki sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Susumu Kusunoki is affiliated with Kindai University in Japan. Their research primarily focuses on medicine and neuroscience, with a significant body of work in neurology. The scientist's contributions extend across several subfields, including neurology, cellular and molecular neuroscience, molecular biology, pathology and forensic medicine, and infectious diseases.

The main topics covered in their research are diverse and include peripheral neuropathies and disorders, hereditary neurological disorders, long-term effects of COVID-19, nerve injury and regeneration, multiple sclerosis research studies, autoimmune neurological disorders and treatments, and the relationship between neurological diseases and metabolism.

Kusunoki has published numerous papers in various scientific venues, with several frequent publication outlets. These include:

  • Journal of Neurology Neurosurgery & Psychiatry
  • Scientific Reports
  • Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Journal of the Neurological Sciences

Notable recent papers authored or co-authored by Kusunoki include:

  • "European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome" (2023), published in European Journal of Neurology
  • "An International Perspective on Preceding Infections in Guillain-Barré Syndrome" (2022), published in Neurology
  • "Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study" (2021), published in Brain
  • "Predicting Outcome in Guillain-Barré Syndrome" (2021), published in Neurology
  • "European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome" (2023), published in Journal of the Peripheral Nervous System

The scientist has frequently collaborated with other researchers, including:

  • Motoi Kuwahara
  • Thomas Harbo
  • Satoshi Kuwabara
  • Makito Hirano
  • Makoto Samukawa

Best Publications

  • Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome: Clinical and immunohistochemical studies

    A. Chiba;S. Kusunoki;H. Obata;R. Machinami

  • Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

    Atsuro Chiba;Susumu Kusunoki;Teruo Shimizu;Ichiro Kanazawa

  • Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study

    Manabu Araki;Takako Matsuoka;Katsuichi Miyamoto;Susumu Kusunoki

  • N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

    Susumu Kusunoki;Atsuro Chiba;Kazuo Kon;Susumu Ando

  • Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy

    Hidenori Ogata;Ryo Yamasaki;Akio Hiwatashi;Nobuyuki Oka

  • Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling

    Seiji Hitoshi;Raewyn M. Seaberg;Cheryl Koscik;Tania Alexson

  • Ganglioside complexes as new target antigens in Guillain-Barré syndrome.

    Ken-ichi Kaida;Daiji Morita;Mami Kanzaki;Keiko Kamakura

  • Anti-neurofascin antibody in patients with combined central and peripheral demyelination

    Nobutoshi Kawamura;Ryo Yamasaki;Tomomi Yonekawa;Takuya Matsushita

  • Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.

    Susumu Kusunoki;Jun Shimizu;Atsuro Chiba;Yoshikazu Ugawa

  • Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia.

    Susumu Kusunoki;Atsuro Chiba;Ichiro Kanazawa

  • Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry

    Susumu Kusunoki;Meiko Shiina;Ichiro Kanazawa

  • Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells

    Masashi Nishio;Satoshi Fukumoto;Satoshi Fukumoto;Keiko Furukawa;Akiko Ichimura

  • Localization of GM1 and GD1b antigens in the human peripheral nervous system.

    Susumu Kusunoki;Atsuro Chiba;Tadashi Tai;Ichiro Kanazawa

  • Clinical Features of Acute Flaccid Myelitis Temporally Associated With an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015.

    Pin Fee Chong;Ryutaro Kira;Harushi Mori;Akihisa Okumura

  • Anti-ganglioside complex antibodies associated with severe disability in GBS.

    K. Kaida;D. Morita;M. Kanzaki;K. Kamakura

  • Acute conduction block in vitro following exposure to antiganglioside sera.

    Keisuke Arasaki PhD;Keisuke Arasaki PhD;Susumu Kusunoki PhD;Norio Kudo PhD;Ichiro Kanazawa PhD

  • Anti-ganglioside complex antibodies in Miller Fisher syndrome

    Ken-ichi Kaida;Mami Kanzaki;Daiji Morita;Keiko Kamakura

  • High resolution proton NMR studies of gangliosides. Structure of two types of GD3 lactones and their reactivity with monoclonal antibody R24

    S Ando;R K Yu;J N Scarsdale;S Kusunoki

  • Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.

    K Kaida;S Kusunoki;K Kamakura;K Motoyoshi

  • Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.

    Kenichi Kaida;Susumu Kusunoki

  • GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome

    S. Kusunoki;M. Iwamori;A. Chiba;S. Hitoshi

Frequent Co-Authors

Ichiro Kanazawa
Ichiro Kanazawa University of Tokyo
Jun-ichi Kira
Jun-ichi Kira Kyushu University
Satoshi Kuwabara
Satoshi Kuwabara Chiba University
Gen Sobue
Gen Sobue Aichi Medical University
Kazuo Motoyoshi
Kazuo Motoyoshi National Defense Medical College
Shoji Tsuji
Shoji Tsuji University of Tokyo
Robert K. Yu
Robert K. Yu Augusta University
Hideki Mochizuki
Hideki Mochizuki Osaka University
Hugh J. Willison
Hugh J. Willison University of Glasgow
Sonoko Misawa
Sonoko Misawa Chiba University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students gravitate toward nursing programs, which offer a strong foundation in patient care and biomedical sciences. Accelerated options like the nurse practitioner accelerated program provide an expedited route for those holding a bachelor's degree in a different field to advance quickly into clinical roles.

For individuals without prior nursing experience, online BSN programs for non nurses are designed to facilitate this transition. These programs combine flexibility with rigorous coursework, preparing students for roles in healthcare settings closely linked to immunological research and patient care.

Admission ease can be a deciding factor. Many prospective students look for programs with less competitive entry requirements, such as the easiest ABSN program to get into, which balances accessibility with quality education.

Additionally, entering the healthcare field via practical nursing roles is another pathway. The easy admission LPN programs offer entry-level training that can lead to careers supporting immunology-related healthcare services or further education.

Best Scientists Citing Susumu Kusunoki

Trending Scientists

Recently Published Articles